Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Anus Neoplasms 1

Interventions

Cisplatin 14Radiotherapy, Intensity-Modulated 12pembrolizumab 7Radiotherapy 7Magnetic Resonance Spectroscopy 7Specimen Handling 6Platinum 6Carboplatin 6Radiation 51,2-diaminocyclohexaneplatinum II citrate 5Taxes 3Surveys and Questionnaires 3Paclitaxel 3Nivolumab 3Fluorodeoxyglucose F18 3Biopsy 3durvalumab 2Drug Therapy 2prednylidene 1peposertib 1niraparib 1exifone 1entinostat 1dostarlimab 1deltacortene 1dehydroftorafur 1cemiplimab 1bintrafusp alfa protein, human 1atezolizumab 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Oropharyngeal Neoplasms × NHS-IL12 immunocytokine × Clear all
NCT04287868 2026-04-13

Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
51 enrolled 16 charts
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡